Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.
Click on an RSS button(s) below and copy the URL into your RSS Reader to receive a feed of updated information from this site.
Not familiar with RSS? RSS is an XML-based (eXtensible Markup Language) format for content distribution that you view with an RSS Reader. There are a wide range of RSS Readers available - Click here for a list of some of the most popular.
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at firstname.lastname@example.org
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.